Home › Funds › Michelson Medical Research Foundation, Inc. › BATRK
Michelson Medical Research Foundation, Inc. position in BATRK
ATLANTA BRAVES HLDGS INC · Consumer Discretionary
Michelson Medical Research Foundation, Inc. reported holding 45,130 shares of BATRK (ATLANTA BRAVES HLDGS INC) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 2.12% of its reported portfolio and ranking #17 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed BATRK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Michelson Medical Research Foundation, Inc.'s BATRK position evolved
Michelson Medical Research Foundation, Inc. first disclosed a stake in BATRK in Q1 2026 at 45,130 shares (US$1.9M). The position peaked in Q3 2026 at 45,130 shares, worth US$2.4M. Across 3 filings, Michelson Medical Research Foundation, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 45,130 shares valued at US$2.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 45.13K | $1.93M | New |
| Q2 2026 | 45.13K | $2.34M | Hold |
| Q3 2026 | 45.13K | $2.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BATRK and 13F data
BATRK (ATLANTA BRAVES HLDGS INC) is a Consumer Discretionary company. 34 other funds we track also report a position in BATRK — the largest reported positions include Atairos Group, Inc. (US$149.3M), Sixth Street Partners Management Company, L.P. (US$113.9M), HAWK RIDGE CAPITAL MANAGEMENT LP (US$102.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BATRK
- Atairos Group, Inc. 2.82M sh · $149.27M · Q3 2026
- Sixth Street Partners Management Company, L.P. 2.15M sh · $113.89M · Q3 2026
- HAWK RIDGE CAPITAL MANAGEMENT LP 1.98M sh · $102.54M · Q2 2026
- Broad Bay Capital Management, LP 1.91M sh · $101.00M · Q3 2026
- GAMCO INVESTORS, INC. ET AL 1.25M sh · $66.42M · Q3 2026
- GABELLI FUNDS LLC 1.22M sh · $64.58M · Q3 2026
- ARISTEIA CAPITAL, L.L.C. 1.04M sh · $54.17M · Q2 2026
- BREACH INLET CAPITAL MANAGEMENT, LLC 778.52K sh · $40.41M · Q2 2026
- Harvey Partners, LLC 756.83K sh · $39.28M · Q2 2026
- Tensile Capital Management LP 753.88K sh · $39.13M · Q2 2026
- Southeastern Asset Management 605.09K sh · $31.40M · Q2 2026
- SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 605.09K sh · $31.40M · Q2 2026
More on Michelson Medical Research Foundation, Inc.
FAQ
How long has Michelson Medical Research Foundation, Inc. held BATRK?
Michelson Medical Research Foundation, Inc. has disclosed BATRK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Michelson Medical Research Foundation, Inc.'s current position in BATRK?
As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 45.13K shares of BATRK (ATLANTA BRAVES HLDGS INC), valued at $2.39M, representing 2.12% of its reported portfolio and ranking #17.
Has Michelson Medical Research Foundation, Inc. been buying or selling BATRK?
In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in BATRK. The position peaked in Q3 2026 at 45.13K shares.
Which other funds hold BATRK?
Other major institutional holders of BATRK include Atairos Group, Inc., Sixth Street Partners Management Company, L.P., HAWK RIDGE CAPITAL MANAGEMENT LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.